1H and 129Xe MRI to detect functional and structural lung disease in sub-clinical cystic fibrosis

L. Smith (Sheffield, United Kingdom), D. Hughes (Sheffield, United Kingdom), H. Chan (Sheffield, United Kingdom), K. Johnson (Madison, United States of America), J. Bray (Sheffield, United Kingdom), O. Rodgers (Sheffield, United Kingdom), G. Collier (Sheffield, United Kingdom), G. Norquay (Sheffield, United Kingdom), A. Biancardi (Sheffield, United Kingdom), P. Hughes (Sheffield, United Kingdom), S. Kotecha (Cardiff, United Kingdom), M. Wildman (Sheffield, United Kingdom), N. West (Sheffield, United Kingdom), A. Horsley (Manchester, United Kingdom), J. Vogel-Claussen (Hannover, Germany), H. Tiddens (Rotterdam, Netherlands), H. Marshall (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom)

Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Session: Advances in care and monitoring of cystic fibrosis
Session type: Oral Presentation
Number: 2131
Disease area: Paediatric lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Smith (Sheffield, United Kingdom), D. Hughes (Sheffield, United Kingdom), H. Chan (Sheffield, United Kingdom), K. Johnson (Madison, United States of America), J. Bray (Sheffield, United Kingdom), O. Rodgers (Sheffield, United Kingdom), G. Collier (Sheffield, United Kingdom), G. Norquay (Sheffield, United Kingdom), A. Biancardi (Sheffield, United Kingdom), P. Hughes (Sheffield, United Kingdom), S. Kotecha (Cardiff, United Kingdom), M. Wildman (Sheffield, United Kingdom), N. West (Sheffield, United Kingdom), A. Horsley (Manchester, United Kingdom), J. Vogel-Claussen (Hannover, Germany), H. Tiddens (Rotterdam, Netherlands), H. Marshall (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom). 1H and 129Xe MRI to detect functional and structural lung disease in sub-clinical cystic fibrosis. 2131

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of 1H MRI and 3He MRI ventilation images in patients with cystic fibrosis and patients with lung cancer
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018



The assessment of short- and long-term changes in lung function in cystic fibrosis using 129Xe MRI
Source: Eur Respir J, 56 (6) 2000441; 10.1183/13993003.00441-2020
Year: 2020



Novel magnetic resonance technique for functional imaging of cystic fibrosis lung disease
Source: Eur Respir J, 50 (6) 1701464; 10.1183/13993003.01464-2017
Year: 2017



Quantitative multivolume proton-magnetic resonance imaging in patients with cystic fibrosis lung disease: comparison with clinical indicators
Source: Eur Respir J, 53 (5) 1702020; 10.1183/13993003.02020-2017
Year: 2019



Proton MRI assessment of lung structure and function in people with cystic fibrosis
Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases
Year: 2021


Detection and monitoring of lung inflammation in cystic fibrosis during respiratory tract exacerbation using diffusion-weighted magnetic resonance imaging
Source: Eur Respir J, 50 (1) 1601437; 10.1183/13993003.01437-2016
Year: 2017



Gadofosveset-enhanced lung magnetic resonance imaging to detect ongoing vascular leak in pulmonary fibrosis
Source: Eur Respir J, 51 (5) 1800171; 10.1183/13993003.00171-2018
Year: 2018



Multivolume magnetic resonance imaging (1H-MRI) for the longitudinal assessment of cystic fibrosis (CF) lung disease: comparison with spirometry
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020




Functional magnetic resonance imaging and lung function tests in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017

Detection of early-stage lung disease in cystic fibrosis; comparing the sensitivity of 3He and 1H MRI, CT and LCI
Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Year: 2014


Evaluation of the peripheral airway microstructure in children with cystic fibrosis (CF) using 3He magnetic resonance imaging
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new therapies and detection of early lung disease
Year: 2012

Assessment of a new magnetic resonance imaging (MRI)-scoring- system for pulmonary changes in patients with cystic fibrosis (CF) – comparison with clinical parameters and high resolution computed tomography (HRCT)
Source: Annual Congress 2006 - New modalities and application in imaging of the chest
Year: 2006


Hyperpolarised 129Xe magnetic resonance imaging to monitor treatment response in children with cystic fibrosis
Source: Eur Respir J, 53 (5) 1802188; 10.1183/13993003.02188-2018
Year: 2019



Imaging cystic fibrosis lung disease with MRI
Source: Eur Respir Monogr 2015; 70: 188-206
Year: 2015


Longitudinal monitoring of lung microstructure with HP gas diffusion-weighted MRI in mild cystic fibrosis children
Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Year: 2017



Longitudinal change in hyperpolarised 129-xenon MR spectroscopy in interstitial lung disease
Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019
Year: 2019


Oxygen-enhanced MRI of the lung in the assessment of chronic obstructive pulmonary disease
Source: Annual Congress 2006 - New modalities and application in imaging of the chest
Year: 2006


Characterizing metabolic abnormality and adipose tissue infiltration in skeletal muscle of COPD patients using 31P MR spectroscopy and MRI imaging
Source: Annual Congress 2012 - The best abstracts in pulmonary rehabilitation
Year: 2012

Changes in magnetic resonance imaging scores and ventilation inhomogeneity in children with cystic fibrosis pulmonary exacerbations
Source: Eur Respir J, 50 (2) 1700244; 10.1183/13993003.00244-2017
Year: 2017